Pharmacokinetics of enoxaparin in COVID-19 critically ill patients

Systematic review and subgroup analysis of the incidence of acute kidney injury (AKI) in patients with COVID-19

(2021) Zhenjian Xu et al.   BMC Nephrology

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit

(2021) et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

(2020) Julie Helms et al.   INTENSIVE CARE MEDICINE

Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID‐19

(2020) Alex C. Spyropoulos et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?

(2020) Tina Dutt et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019

(2020) Lisa K. Moores et al.   CHEST

Haemodynamic characteristics of COVID ‐19 patients with acute respiratory distress syndrome requiring mechanical ventilation. An invasive assessment using right heart catheterization

(2020) Sergio Caravita et al.   EUROPEAN JOURNAL OF HEART FAILURE

Trauma patients with lower extremity and pelvic fractures: Should anti -factor Xa trough level guide prophylactic enoxaparin dose?

(2018) Navpreet K. Dhillon et al.   International Journal of Surgery

European guidelines on perioperative venous thromboembolism prophylaxis

(2017) Jacques Duranteau et al.   EUROPEAN JOURNAL OF ANAESTHESIOLOGY

Pharmacological and Mechanical Thromboprophylaxis in Critically Ill Patients: a Network Meta-Analysis of 12 Trials

(2016) Jonghanne Park et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

Abnormal laboratory results: Anti-Xa assays

(2016) Michael Barras   Australian Prescriber

Screening of patients with augmented renal clearance in ICU: taking into account the CKD-EPI equation, the age, and the cause of admission

(2015) Stéphanie Ruiz et al.   Annals of Intensive Care

The effect of pathophysiology on pharmacokinetics in the critically ill patient — Concepts appraised by the example of antimicrobial agents

(2014) Stijn I. Blot et al.   ADVANCED DRUG DELIVERY REVIEWS

Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients

(2014) Molly E. Droege et al.   Journal of Trauma and Acute Care Surgery

Alternative dosing of prophylactic enoxaparin in the trauma patient: is more the answer?

(2013) Tammy R. Kopelman et al.   AMERICAN JOURNAL OF SURGERY

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

What do we learn from repeated population analyses?

(2013) Stephen B. Duffull et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Augmented Renal Clearance in the ICU

(2013) Andrew A. Udy et al.   CRITICAL CARE MEDICINE

Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models

(2011) Martin Bergstrand et al.   AAPS Journal

Interpreting population pharmacokinetic-pharmacodynamic analyses - a clinical viewpoint

(2010) Stephen B. Duffull et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY